Clinical Trial: Pembro With Radiation With or Without Olaparib
Study Status: Completed
Recruit Status: RECRUITING
Condition: Prostate Cancer
Study Type: INTERVENTIONAL
Official Title: Phase II Study of Pembrolizumab in Combination With Radiation With or Without Olaparib in Localized High-risk Prostate Cancer
Brief Summary:
This trial will evaluate whether the immune-sensitizing effects of immunotherapy (Pembrolizumab) and radiation with or without a PARP-inhibitor (Olaparib) will increase the effects of immunotherapy in men with high-risk localized prostate cancer.
Read more